Pubblicazioni

Bevacizumab-induced hypertension as a predictor of clinical outcome in metastatic colorectal cancer: An individual patient data-based pooled analysis of two randomized studies and a systematic review of the literature

2022 - CANCER TREATMENT REVIEWS

Lombardi, P.; Rossini, D.; Crespi, V.; Germani, M. M.; Bergamo, F.; Pietrantonio, F.; Santini, D.; Allegrini, G.; Daniel, F.; Pagani, F.; Antoniotti, C.; Zaniboni, A.; Conca, V.; Latiano, T. P.; Boccaccino, A.; Passardi, A.; Tamburini, E.; Masi, G.; Di Maio, M.; Cremolini, C.

Intensified Total Neoadjuvant Therapy Versus Intensified Concurrent Chemoradiotherapy in Locally Advanced Rectal Cancer: A Propensity Score Matching Analysis

2022 - ANTICANCER RESEARCH

DE Felice, Francesca; Musio, Daniela; Iafrate, Franco; Caponnetto, Salvatore; Picone, Vincenzo; D'Ambrosio, Giancarlo; Magliocca, Fabio Massimo; Tozzi, Francesca; DE Toma, Giorgio; Tombolini, Vincenzo; Cortesi, Enrico

A multicentre single arm phase 2 trial of neoadjuvant pyrotinib and letrozole plus dalpiciclib for triple-positive breast cancer

2022 - NATURE COMMUNICATIONS

Niu, Nan; Qiu, Fang; Xu, Qianshi; He, Guijin; Gu, Xi; Guo, Wenbin; Zhang, Dianlong; Li, Zhigao; Zhao, Yi; Li, Yong; Li, Ke; Zhang, Hao; Zhang, Peili; Huang, Yuanxi; Zhang, Gangling; Han, Hongbin; Cai, Zhengang; Li, Pengfei; Xu, Hong; Chen, Guanglei; Xue, Jinqi; Jiang, Xiaofan; Jahromi, Alireza Hamidian; Li, Jinshi; Zhao, Yu; de Faria Castro Fleury, Eduardo; Huo, Shiwen; Li, Huajun; Jerusalem, Guy; Tripodi, Domenico; Liu, Tong; Zheng, Xinyu; Liu, Caigang

Vemurafenib plus rituximab in refractory or relapsed hairy-cell leukemia

2021 - NEW ENGLAND JOURNAL OF MEDICINE

Tiacci, E.; De Carolis, L.; Simonetti, E.; Capponi, M.; Ambrosetti, A.; Lucia, E.; Antolino, A.; Pulsoni, A.; Ferrari, S.; Zinzani, P. L.; Ascani, S.; Perriello, V. M.; Rigacci, L.; Gaidano, G.; Seta, R. D.; Frattarelli, N.; Falcucci, P.; Foa, R.; Visani, G.; Zaja, F.; Falini, B.

Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation in mantle cell lymphoma: results of a Fondazione Italiana Linfomi (FIL) multicentre, randomised, phase 3 trial

2021 - THE LANCET. HAEMATOLOGY

Ladetto, M.; Cortelazzo, S.; Ferrero, S.; Evangelista, A.; Mian, M.; Tavarozzi, R.; Zanni, M.; Cavallo, F.; Di Rocco, A.; Stefoni, V.; Pagani, C.; Re, A.; Chiappella, A.; Balzarotti, M.; Zilioli, V. R.; Gomes da Silva, M.; Arcaini, L.; Molinari, A. L.; Ballerini, F.; Ferreri, A. J. M.; Puccini, B.; Benedetti, F.; Stefani, P. M.; Narni, F.; Casaroli, I.; Stelitano, C.; Ciccone, G.; Vitolo, U.; Martelli, M.

Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer Progression

2021 - GASTROENTEROLOGY

Hu, T.; Shukla, S. K.; Vernucci, E.; He, C.; Wang, D.; King, R. J.; Jha, K.; Siddhanta, K.; Mullen, N. J.; Attri, K. S.; Murthy, D.; Chaika, N. V.; Thakur, R.; Mulder, S. E.; Pacheco, C. G.; Fu, X.; High, R. R.; Yu, F.; Lazenby, A.; Steegborn, C.; Lan, P.; Mehla, K.; Rotili, D.; Chaudhary, S.; Valente, S.; Tafani, M.; Mai, A.; Auwerx, J.; Verdin, E.; Tuveson, D.; Singh, P. K.

Cetuximab rechallenge plus avelumab in pretreated patients with RAS Wild-type Metastatic Colorectal Cancer: The Phase 2 Single-Arm Clinical CAVE Trial

2021 - JAMA ONCOLOGY

Martinelli, E.; Martini, G.; Famiglietti, V.; Troiani, T.; Napolitano, S.; Pietrantonio, F.; Ciardiello, D.; Terminiello, M.; Borrelli, C.; Vitiello, P. P.; De Braud, F.; Morano, F.; Avallone, A.; Normanno, N.; Nappi, A.; Maiello, E.; Latiano, T.; Falcone, A.; Cremolini, C.; Rossini, D.; Santabarbara, G.; Pinto, C.; Santini, D.; Cardone, C.; Zanaletti, N.; Di Liello, A.; Renato, D.; Esposito, L.; Marrone, F.; Ciardiello, F.

Clinical Outcomes of Metastatic Renal Carcinoma Following Disease Progression to Programmed Death (PD)-1 or PD-L1 Inhibitors (IO): A Meet-URO Group Real World Study (Meet-Uro 7)

2021 - AMERICAN JOURNAL OF CLINICAL ONCOLOGY: CANCER CLINICAL TRIALS

Santini, D; Stellato, M; De Giorgi, U; Pantano, F; De Lisi, D; Casadei, C; Maruzzo, M; Bimbatti, D; Naglieri, E; Buti, S; Bersanelli, M; De Vivo, R; Di Lorenzo, G; Sbrana, A; Verzoni, E; Soraru', M; Fornarini, G; Mucciarini, C; Grillone, F; Mini, E; Vignani, F; Attademo, L; Pignata, S; Procopio, G

Second-line eribulin in triple negative metastatic breast cancer patients. Multicentre retrospective study: The tetris trial

2021 - INTERNATIONAL JOURNAL OF MEDICAL SCIENCES

Krasniqi, E.; Pizzuti, L.; Valerio, M. R.; Capomolla, E.; Botti, C.; Sanguineti, G.; Marchetti, P.; Anselmi, E.; Tomao, S.; Giordano, A.; Ficorella, C.; Cannita, K.; Livi, L.; Meattini, I.; Mauri, M.; Greco, F.; Veltri, E. M.; Michelotti, A.; Moscetti, L.; Giotta, F.; Lorusso, V.; Paris, I.; Tomao, F.; Santini, D.; Tonini, G.; Villa, A.; Gebbia, V.; Gamucci, T.; Ciliberto, G.; Sperduti, I.; Mazzotta, M.; Barba, M.; Vici, P.

CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies

2021 - BRITISH JOURNAL OF CANCER

Moretto, R.; Rossini, D.; Conca, V.; Lonardi, S.; Rasola, C.; Antoniotti, C.; Santini, D.; Marmorino, F.; Tomasello, G.; Borelli, B.; Caponnetto, S.; Zucchelli, G.; Zaniboni, A.; Ambrosini, M.; Buonadonna, A.; Fanchini, L.; Cupini, S.; Masi, G.; Falcone, A.; Cremolini, C.

Inflammatory myofibroblastic tumor: The experience of the European pediatric Soft Tissue Sarcoma Study Group (EpSSG)

2020 - EUROPEAN JOURNAL OF CANCER

Casanova, M.; Brennan, B.; Alaggio, R.; Kelsey, A.; Orbach, D.; van Noesel, M. M.; Corradini, N.; Minard-Colin, V.; Zanetti, I.; Bisogno, G.; Gallego, S.; Merks, J. H. M.; De Salvo, G. L.; Ferrari, A.

Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan A Phase 2 Single-Arm Clinical Trial

2019 - JAMA ONCOLOGY

Cremolini, C; Rossini, D; Dell'Aquila, E; Lonardi, S; Conca, E; Del Re, M; Busico, A; Pietrantonio, F; Danesi, R; Aprile, G; Tamburini, E; Barone, C; Masi, G; Pantano, F; Pucci, F; Corsi, Dc; Pella, N; Bergamo, F; Rofi, E; Barbara, C; Falcone, A; Santini, D

Dabrafenib-trametinib combination in 'field-practice': An Italian experience

2018 - FUTURE ONCOLOGY

Depenni, R.; De Rosa, F.; Greco, S.; Ridolfi, L.; Pellacani, G.; Ponti, G.; Cascinu, S.; Guidoboni, M.

Hepatoblastoma in children aged less than six months at diagnosis: A report from the SIOPEL group

2018 - PEDIATRIC BLOOD & CANCER

Dall'Igna, Patrizia; Brugieres, Laurence; Christin Anne, Sanlaville; Maibach, Rudolf; Casanova, Michela; Alaggio, Rita; de Goyet Jean de, Ville; Zsiros, Jozsef; Morland, Bruce; Czauderna, Piotr; Childs, Margaret; Aronson Daniel, C; Branchereau, Sophie; Brock, Penelope; Perilongo, Giorgio

A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (â¤16Â years) low grade gliomaÂ â A final report

2017 - EUROPEAN JOURNAL OF CANCER

Gnekow, A. K.; Walker, D. A.; Kandels, D.; Picton, S.; Perilongo, G.; Grill, J.; Stokland, T.; Sandstrom, P. E.; Warmuth-Metz, M.; Pietsch, T.; Giangaspero, F.; Schmidt, R.; Faldum, A.; Kilmartin, D.; De Paoli, A.; De Salvo, G. L.; Gnekow, A. K.; Slavc, I.; Perilongo, G.; Picton, S.; Walker, D.; Stokland, T.; Sandstrom, P. E.; Clausen, N.; Arola, M.; Jonsson, O. G.; Cruz, O.; Navajas, A.; Teijeiro, A.; Grill, J.; Kalifa, C.; Raquin, M. -A.; Verlooy, J.; Hans, V.; Pietsch, T.; Scheurlen, W.; Hainfellner, J.; Giangaspero, F.; Ironside, J.; Robson, K.; Skullerud, K.; Scheie, D.; Nn, ; Ruchoux, M. -M.; Jouvet, A.; Figarella-Branger, D.; Lellouch-Toubiana, A.; Warmuth-Metz, M.; Prayer, D.; Calderone, M.; Jaspan, T.; Bakke, S. J.; Vazquez, E.; Couanet, D.; Kortmann, R. D.; Diekmann, K.; Scarzello, G.; Taylor, R.; Lote, K.; Giralt, J.; Carrie, C.; Habrand, J. L.; Soerensen, N.; Czech, T.; Chumas, P.; Gustavson, B.; Zerah, M.; Wabbels, B.; Pinello, M. L.; Fielder, A.; Simmons, I.; Christoffersen, T.; Calaminus, G.; Brockmann, K.; Straeter, R.; Ebinger, F.; Hernaiz-Driever, P.; Lackner, H.; Kennedy, C.; Glaser, A.; Stromberg, B.; Indiano, J. M.; Rodary, C.; Bouffet, E.; Frappaz, D.; Faldum, A.; Emser, A.; De Salvo, G. L.; Stephens, S.; Machin, D.; Le Deley, M. -C.; Egeland, T.; Freemann, C.; Schrappe, M.; Sposto, R.

SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab

2017 - MEDICAL ONCOLOGY

Meattini, Icro; Curigliano, Giuseppe; Terziani, Francesca; Becherini, Carlotta; Airoldi, Mario; Allegrini, Giacomo; Amoroso, Domenico; Barni, Sandro; Bengala, Carmelo; Guarneri, Valentina; Marchetti, Paolo; Martella, Francesca; Piovano, Pierluigi; Vannini, Agnese; Desideri, Isacco; Tarquini, Roberto; Galanti, Giorgio; Barletta, Giuseppe; Livi, Lorenzo

Low-dose clofarabine in combination with a standard remission induction in patients aged 18-60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: Combined phase I/II results of the EORTC/GIMEMA AML-14A trial

2017 - HAEMATOLOGICA

Selleslag, Dominik; Suciu, Stefan; Meloni, Giovanna; Muus, Petra; Halkes, Constantijn J. M.; Venditti, Adriano; Ramadan, Safaa M.; Pruijt, Hans; Meert, Liv; Vignetti, Marco; Marie, Jean-Pierre; Wittnebel, SÃ©bastian; de Witte, Theo; Amadori, Sergio; Willemze, Roelof; Baron, FrÃ©dÃ©ric

Improved outcomes with retinoic acid and arsenic trioxide compared with retinoic acid and chemotherapy in non-high-risk acute promyelocytic leukemia: Final results of the randomized Italian-German APL0406 trial

2017 - JOURNAL OF CLINICAL ONCOLOGY

Platzbecker, Uwe; Avvisati, Giuseppe; Cicconi, Laura; Thiede, Christian; Paoloni, Francesca; Vignetti, Marco; Ferrara, Felicetto; Divona, Mariadomenica; Albano, Francesco; Efficace, Fabio; Fazi, Paola; Sborgia, Marco; Di Bona, Eros; Breccia, Massimo; Borlenghi, Erika; Cairoli, Roberto; Rambaldi, Alessandro; Melillo, Lorella; La Nasa, Giorgio; Fiedler, Walter; Brossart, Peter; Hertenstein, Bernd; Salih, Helmut R.; Wattad, Mohammed; LÃ¼bbert, Michael; Brandts, Christian H.; HÃ¤nel, Mathias; RÃ¶llig, Christoph; Schmitz, Norbert; Link, Hartmut; Frairia, Chiara; Pogliani, Enrico Maria; Fozza, Claudio; D'Arco, Alfonso Maria; Di Renzo, Nicola; Cortelezzi, Agostino; Fabbiano, Francesco; DÃ¶hner, Konstanze; Ganser, Arnold; DÃ¶hner, Hartmut; Amadori, Sergio; Mandelli, Franco; Ehninger, Gerhard; Schlenk, Richard F.; Lo-Coco, Francesco

Radiologic Response Assessment in Pediatric Soft Tissue Sarcoma: Computed-Assisted Volume Evaluation

2017 - THE JOURNAL OF PEDIATRICS

Orsatti, G.; Beltrame, V.; Crimi, F.; Frigo, A. C.; Bisogno, G.; Stramare, R.

Anaplastic thyroid carcinoma and foscarnet use in a multitarget treatment documented by 18F-FDG PET/CT: a case report

2017 - MEDICINE

Giannetta, Elisa; Isidori, Andrea M.; Durante, Cosimo; DI Gioia, Cira; Longo, Flavia; Tombolini, Vincenzo; Bulzonetti, Nadia; Graziadio, Chiara; Pofi, Riccardo; Gianfrilli, Daniele; Verrienti, Antonella; Carletti, Raffaella; Filetti, Sebastiano; Lenzi, Andrea; Baroli, Alberto

Neoadjuvant sequential docetaxel followed by high-dose epirubicin in combination with cyclophosphamide administered concurrently with trastuzumab. The DECT trial

2016 - JOURNAL OF CELLULAR PHYSIOLOGY

Pizzuti, Laura; Barba, Maddalena; Giannarelli, Diana; Sergi, Domenico; Botti, Claudio; Marchetti, Paolo; AnzÃ , Michele; Maugeri SaccÃ , Marcello; Natoli, Clara; DI FILIPPO, Simona; Catenaro, Teresa; Tomao, Federica; Amodio, Antonella; Carpano, Silvia; Perracchio, Letizia; Mottolese, Marcella; Di Lauro, Luigi; Sanguineti, Giuseppe; Di Benedetto, Anna; Giordano, Antonio; Vici, Patrizia

Bevacizumab as first-line treatment in HER2-negative advanced breast cancer. Pros and cons

2016 - TUMORI

Sini, Valentina; Cassano, Alessandra; Corsi, Domenico; De Laurentiis, Michele; Gamucci, Teresa; Mauri, Mariella; Naso, Giuseppe; Roselli, Mario; Ruggeri, Enzo Maria; Tonini, Giuseppe; Vici, Patrizia; Zampa, Germano; Marchetti, Paolo

Is the chemotherapy era in advanced non-small cell lung cancer really over? Maybe not yet

2016 - TUMORI

Lo Russo, Giuseppe; Imbimbo, Martina; Garassino, Marina Chiara

Bendamustine in combination with gemcitabine and vinorelbine is an effective regimen as induction chemotherapy before autologous stem-cell transplantation for relapsed or refractory Hodgkin lymphoma: Final results of a multicenter phase II study

2016 - JOURNAL OF CLINICAL ONCOLOGY

Santoro, Armando; Mazza, Rita; Pulsoni, Alessandro; Re, Alessandro; Bonfichi, Maurizio; Zilioli, Vittorio Ruggero; Salvi, Flavia; Merli, Francesco; Anastasia, Antonella; Luminari, Stefano; Annechini, Giorgia; Gotti, Manuel; Peli, Annalisa; Liberati, Anna Marina; Di Renzo, Nicola; Castagna, Luca; Giordano, Laura; Carlo-Stella, Carmelo

On and off metronomic oral vinorelbine in elderly women with advanced breast cancer

2015 - TUMORI

De Iuliis, Francesca; Salerno, Gerardo; Taglieri, Ludovica; Lanza, Rosina; Scarpa, Susanna